However, of the claims so far of rocuronium-induced IgE/FcεRI-mediated anaphylaxis mitigated by sugammadex, symptoms and diagnoses overwhelmingly indicate systemic anaphylaxis with cutaneous reactions uncommon. The gene discussed is IGHE; the disease is anaphylaxis.